Rex announces Distribution Agreements in Europe

15 May 2015

Rex Bionics plc

("Rex Bionics" or the "Company")

Rex Bionics plc announces Distribution Agreements in Europe

Rex Bionics plc (AIM:RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users is pleased to announce that it has signed new agreements covering the distribution of REX in Denmark; and also in Belgium, The Netherlands and Luxembourg (Benelux).

In Denmark, REX will be represented by Blue-Ocean Robotics, and in Benelux by Ortho-Medico. The commercialisation of REX in these markets will begin in the next few weeks.

Based on prevalence data from the World Health Organisation, the Company estimates that as many as 20,000 citizens in Denmark and the Benelux countries live with a spinal cord injury.1

Crispin Simon, Chief Executive, Rex Bionics plc said: "We are delighted with these new agreements. Our new partners bring expertise in robotics and Neuro-rehabilitation and they will be an integral part of our near-term commercialisation activities and of our long-term strategic development programmes."

"We are in discussion with distribution partners of a similar quality in other countries and plan to establish coverage in other important markets over the next 24 months."

John Erland Østergaard, Partner and Director, Blue-Ocean Roboticssaid:  "We are very pleased to have been chosen as REX's representative in Denmark and believe that there is a great opportunity here for this exciting technology. We can see a need for and a strong interest in products like REX's from Danish Hospitals and Private Clinics and several demos of the product has been scheduled initially."  

Geert Meskens, COO Ortho-Medico said: '' "We are very pleased to be able to market REX in Benelux as we believe that it is an exciting technology that can make a tremendous difference in the patient's life and rehabilitation."

For further information please contact:

Rex Bionics PlcCrispin Simon, Chief Executive Officer+44 (0) 748 3 167851Peter Worrall, Chief Financial Officer+44 (0) 142 864 5416

Stifel Nicolaus Europe Limited (NOMAD and Broker)Jonathan Senior/Giles Balleny+44 (0) 20 7710 7600

Consilium Strategic CommunicationsMary-Jane Elliott / Jessica Hodgson / Chris Welsh / Lindsey [email protected]+44 (0) 203 709 5700

About Blue-Ocean Robotics

Founded in 2013, Blue Ocean Robotics is a new class of company with a focus on commercializing robotics R&D. It was founded with its roots in the Nordic robotics eco-system with strongholds in several industries, including healthcare and welfare, education, oil and gas and mining. The company is part of the robot and health technology cluster in Odense, Denmark, which focuses on bringing together healthcare and technology companies, sharing knowledge and testing facilities.Blue Ocean Robotics develops and introduces innovative market-ready robots for a broad range of industries focusing on early-stage robotic technologies and first-mover initiatives towards the markets. Its' expertise is to create and develop robotic products with the direct participation of end-user clients.

Blue Ocean Robotics is closely linked with public sector organisations and has developed a strong experience and expertise in PPP (Public-Private Partnerships) with hospitals, rehab centres, nursing homes and schools. The company markets and distributes robotic products for upper body rehabilitation including Proficio designed to help patients recover from spinal cord injury, traumatic brain injury, and stroke.

About Ortho-Medico

Founded in 1995, as a company within the B&Co medical group, Ortho-Medico has been a market leader in Benelux for over a decade and has a strong market position in the Netherlands. Its success is founded on providing customers with a very high-quality and complete product portfolio, close collaboration with specialists and orthopaedic technicians, very quick terms of delivery, reliable advice and an attitude which is aimed at finding solutions.

Ortho-Medico has experienced sales teams that cover the whole of Benelux and are fully targeted on the activities of orthopaedic surgeons, doctors in physiotherapy, rehabilitation doctors, orthotists and prosthetists, orthopedic shoe technicians, vascular surgeons and neuro-surgeons.

Ortho-Medico has full range of orthopaedic products for all ages and symptoms and markets its products for both home use and for physiotherapy use in rehabilitation clinics and hospitals. Shockwave for medical use and sophisticated CAD CAM apparatus for tailor-made orthopaedic aids round off the whole range.

About Rex Bionics

Rex Bionics (AIM: RXB) is the UK AIM-listed pioneer of the REX Robot that enhances the mobility of wheel-chair users. Founded in Auckland, New Zealand by two robotics engineers with first-hand experience of wheelchair users and their needs, Rex Bionics is working with physiotherapists to develop the practice of Robot-Assisted Physiotherapy (RAP). In a session of RAP, REX lifts patients from a sitting position into a robot-supported standing position, allowing them to take part in a set of supported walking and stretching exercises, designed by specialist physiotherapists.

Wheelchair users are at risk of developing numerous medical complications from extended periods of sitting. By enabling them to spend more time standing, walking and exercising, REX may offer significant health benefits, including improved sleep, cardiovascular performance, maintenance of joint range, and a reduction in common abdominal problems and prescription drug use. A programme of clinical trials is now under way to evaluate these potential benefits.

REX can be used by people with complete spinal cord injury, as well as people who have suffered a stroke or other traumatic brain injury; and people with multiple sclerosis and muscular dystrophy. REX P, for use in the home, enables users to walk and stand with their hands free - providing more work and recreation options.

In May 2014, Rex Bionics joined AIM with a fundraising of £10 million (gross) to scale up production, distribution and marketing internationally, in order to support growing demand for both REX products as well as developing the next generation of REX devices, REX 3.

REX is not approved for At-Home use in the United States of America.

1. World Health Organisation: International Perspectives on Spinal Injury, 2013.

Ends